HOME Top Market Reports Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: October 2015
Report Code: PH 1262

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global Active Pharmaceutical Ingredient Market is expected to reach USD 205.51 billion by 2020 from USD 150 billion in 2015, at a CAGR of 6.5% during the forecast period

Factors such as the increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets for biosimilars and increasing scope for Highly potent active ingredients are driving market growth. On the other hand, stringent regulatory requirements and global economic recession may restrict market growth.

In 2015, North America is expected to dominate the Active Pharmaceutical Ingredient market. The high market share of this region is attributed to overall growth in the pharmaceutical industry in this region including the increasing government focus on generic drugs, rising demand for biological and specialty drugs, and the technological advances among others.

Key market players Teva Pharmaceuticals limited (Israel), Sun Pharmaceuticals Industries Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Aurobindo (India), Novartis International AG (Switzerland), Boehringer Ingelheim (Germany), Albemarle Corporation (U.S.), Sigma Aldrich (U.S.), Mylan (U.K.), Allergan plc. (Ireland).

Stakeholders include Manufacturers of API Distributors and Suppliers of APIs, Potential Investors in the API Market, Pharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations and Healthcare Payers

Scope of the Report

This market study covers the different components of the active pharmaceutical ingredient market. In this report the API market is segmented of the basis of type of API which include innovative and generic API, on the basis of type of synthesis which include Synthetic and Biotech API, on the basis of type of manufacturer which included captive and merchant manufacturers and on the basis of therapeutic categories. These segments are covered for arriving at global market size for 2014 to 2020.

API Market, by Type of synthesis

  • Synthetic APIs
    • Innovative
    • Generic
  • Biotech API
    • By product
      • Monoclonal antibodies
      • Recombinant proteins
      • Vaccines
    • By type
      • Innovative
      • Generic

API Market, by type of manufacturer

  • Captive APIs
    • Innovative
    • Generic
  • Merchant APIs
    • Innovative
    • Generic

API Market, by type

  • Innovative APIs
  • Generic APIs

API Market, by Therapeutic Area

  • Oncology
  • Diabetes
  • Cardiovascular disorders
  • CAN and neurological disorders
  • Pain management
  • Orthopedic disorders
  • Nephrology
  • Ophthalmology
  • Pulmonology
  • Gastrointestinal disorders
  • Endocrinology

HPAPI market

  • By type of synthesis
    • Synthetic HPAPIs
    • Biotech HPAPIs
  • By type of manufacturer
    • Captive HPAPIs
    • Merchant HPAPIs
  • By type
    • Innovative HPAPIs
    • Generic HPAPIs

API Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • RoE
  • Asia
    • India
    • China
    • Japan
    • South Korea
    • RoA
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Additional company profiling

Company profiles for 10 additional companies.

Market share analysis

Customized market surveys and market share analysis for the API market

Table of Contents

1 Introduction (Page No. - 18 )
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Limitations
    1.5 Currency
    1.6 Stakeholders

2 Research Methodology (Page No. - 21 )
    2.1 Research Data
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions and Limitations
           2.4.1 Assumptions
           2.4.2 Limitations

3 Executive Summary (Page No. - 30 )

4 Premium Insights (Page No. - 39 )
    4.1 Active Pharmaceutical Ingredient Market, By Type
    4.2 Active Pharmaceutical Ingredient Market, By Therapeutic Area
    4.3 Active Pharmaceutical Ingredient, By Type of Synthesis
    4.4 Active Pharmaceutical Ingredient Market, By Type of Manufacturer
    4.5 Geographic Snapshot 
    4.6 High-Potency Active Pharmaceutical Ingredient Market, By Type
    4.7 High-Potency Active Pharmaceutical Ingredient Market, By Type of Synthesis
    4.8 High-Potency Active Pharmaceutical Ingredient Market, By Type of Manufacturer
    4.9 Geographic Snapshot of the High-Potency Active Pharmaceutical Ingredient Market

5 Market Overview (Page No. - 47 )
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Type
           5.2.2 Market Segmentation, By Synthesis Method
           5.2.3 Market Segmentation, By Type of Manufacturer
           5.2.4 Market Segmentation, By Therapeutic Area
           5.2.5 Market Segmentation, By Region
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Incidence of Lifestyle and Age-Related Diseases
                    5.3.1.2 Rising Cancer Prevalence Across the Globe
                    5.3.1.3 Technological Advancements in API Manufacturing
           5.3.2 Restraints
                    5.3.2.1 Stringent Regulatory Requirements
                    5.3.2.2 Economic Recession
           5.3.3 Opportunities
                    5.3.3.1 Emerging Biosimilars Market
                    5.3.3.2 Increasing Scope for Highly Potent Active Pharmaceutical Ingredient
           5.3.4 Challenges
                    5.3.4.1 Product Differentiation - A Major Concern for API Manufacturers

6 Active Pharmaceutical Ingredient Market, By Synthesis (Page No. - 57 )
    6.1 Synthetic Active Pharmaceutical Ingredient
    6.2 Synthetic Active Pharmaceutical Ingredient, By Type
           6.2.1 Innovative Synthetic APIS
           6.2.2 Generic Synthetic APIS
    6.3 Biotech Active Pharmaceutical Ingredient
           6.3.1 Biotech APIS Market, By Product
                    6.3.1.1 Monoclonal Antibodies
                    6.3.1.2 Recombinant Proteins
                    6.3.1.3 Vaccines
           6.3.2 Biotech APIS Market, By Type
                    6.3.2.1 Innovative Biotech APIS
                    6.3.2.2 Biogenerics/Biosimilars

7 Active Pharmaceutical Ingredient Market, By Type of Manufacturer (Page No. - 72 )
    7.1 Introduction
    7.2 Captive API Manufacturers
    7.3 Merchant API Manufacturers
           7.3.1 Merchant API Manufacturers Market, By Type
7.3.1.1 Innovative APIS
7.3.1.2 Generic APIS

8 Active Pharmaceutical Ingredient Market, By Type (Page No. - 82 )
    8.1 Introduction
    8.2 Innovative APIS Segment
    8.3 Generic APIS Segment

9 Active Pharmaceutical Ingredient Market, By Therapeutic Area (Page No. - 88 )
    9.1 Oncology
    9.2 Diabetes
    9.3 Cardiovascular Disease
    9.4 Cns and Neurological Disorders
    9.5 Orthopedic Disorders
    9.6 Nephrology
    9.7 Ophthalmology
    9.8 Pulmonology
    9.9 Gastrointestinal Disorders
    9.10 Endocrinology

10 High-Potency Active Pharmaceutical Ingredient Market (Page No. - 96 )
     10.1 Introduction
             10.1.1 Hpapi Classification
             10.1.2 Overview: Hpapi Global Market
             10.1.3 Manufacturing Capabilities
                        10.1.3.1 Handling Requirements
                        10.1.3.2 Personnel Considerations
                        10.1.3.3 Plant and Equipment
                        10.1.3.4 Technology
     10.2 High-Potency Active Pharmaceutical Ingredient Market, By Product
             10.2.1 Hpapi Market, By Type
                        10.2.1.1 Innovative Hpapi Sector
                        10.2.1.2 Generic Hpapi Sector
     10.3 High-Potency Active Pharmaceutical Ingredient Market, By Type of Manufacturer
             10.3.1 Captive Hpapi Sector
             10.3.2 Merchant Hpapi Sector
     10.4 High-Potency Active Pharmaceutical Ingredient Market, By Method of Synthesis

11 Active Pharmaceutical Ingredient Market, By Region (Page No. - 117 )
     11.1 Introduction
     11.2 Pest Analysis
             11.2.1 Political Factors
             11.2.2 Economical Factors
             11.2.3 Social Factors
             11.2.4 Technological Factors
     11.3 North America
             11.3.1 North America: API Market
             11.3.2 North America: High-Potency Active Pharmaceutical Ingredients Market
             11.3.3 U.S.: API Market
             11.3.4 U.S.: High-Potency Active Pharmaceutical Ingredients Market
             11.3.5 Canada: API Market
             11.3.6 Canada: High-Potency Active Pharmaceutical Ingredient Market
     11.4 Europe
             11.4.1 Europe: API Market
             11.4.2 Europe: High-Potency Active Pharmaceutical Ingredient Market
             11.4.3 U.K.: Active Pharmaceutical Ingredient Market
             11.4.4 U.K.: High-Potency Active Pharmaceutical Ingredient Market
             11.4.5 France: API Market
             11.4.6 France: High-Potency Active Pharmaceutical Ingredient Market
             11.4.7 Germany: API Market
             11.4.8 Germany: High-Potency Active Pharmaceutical Ingredient Market
             11.4.9 Spain: API Market
             11.4.10 Spain: High-Potency Active Pharmaceutical Ingredient Market
             11.4.11 Italy: API Market
             11.4.12 Italy: High-Potency Active Pharmaceutical Ingredient Market
             11.4.13 RoE: API Market
             11.4.14 RoE: High-Potency Active Pharmaceutical Ingredient Market
     11.5 Asia
             11.5.1 Asia: API Market
             11.5.2 Asia: High-Potency Active Pharmaceutical Ingredient Market
             11.5.3 India: API Market
             11.5.4 India: High-Potency Active Pharmaceutical Ingredient Market
             11.5.5 Japan: API Market
             11.5.6 Japan: High-Potency Active Pharmaceutical Ingredient Market
             11.5.7 South Korea: API Market
             11.5.8 South Korea: High-Potency Active Pharmaceutical Ingredient Market
             11.5.9 China: API Market
             11.5.10 China: High-Potency Active Pharmaceutical Ingredient Market
             11.5.11 RoA: API Market
             11.5.12 RoA: High-Potency Active Pharmaceutical Ingredient Market
     11.6 RoW
             11.6.1 RoW: API Market
             11.6.2 RoW: High-Potency Active Pharmaceutical Ingredient Market

12 Competitive Landscape (Page No. - 156 )
     12.1 Competitive Situation and Trends
             12.1.1 New Product Launches
             12.1.2 Mergers and Acquisitions
             12.1.3 Partnerships, Agreements, Collaborations, and Joint Ventures
             12.1.4 Expansion

13 Company Profiles (Page No. - 162 )
     13.1 Introduction
     13.2 Teva Pharmaceutical Industries Limited
             13.2.1 Business Overview
             13.2.2 Products Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Dr. Reddy’s Laboratories Ltd.
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Sun Pharmaceutical Industries Ltd.
             13.4.1 Products Offered
             13.4.2 Recent Development
             13.4.3 MnM View 
     13.5 Aurobindo Pharma Ltd.
             13.5.1 Products Offered
             13.5.2 Recent Developments
             13.5.3 MnM View
     13.6 Novartis International AG
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
     13.7 Albemarle Corporation
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
     13.8 Sigma-Aldrich Corporation
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Mylan Inc.
             13.9.1 Business Overview
             13.9.2 Products Offered
             13.9.3 Recent Developments
     13.10 Allergan PLC
              13.10.1 Business Overview
              13.10.2 Products Offered
              13.10.3 Recent Developments
     13.11 Boehringer Ingelheim
              13.11.1 Business Overview
              13.11.2 Products Offered
              13.11.3 Recent Developments

14 Appendix (Page No. - 192 )
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments, By Company, 2012-2015
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports 


List of Tables (121 Tables)

Table 1 Global Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013–2020 (USD Billion) 57
Table 2 Global Synthetic Active Pharmaceutical Ingredient Market Size, By Region, 2013–2020 (USD Billion) 59
Table 3 North America: Synthetic Active Pharmaceutical Ingredient Market Size, By Country, 2013–2020 (USD Billion) 59
Table 4 Europe: Synthetic Active Pharmaceutical Ingredient Market Size, By Country, 2013–2020 (USD Billion) 60
Table 5 Asia: Synthetic Active Pharmaceutical Ingredient Market Size, By Region, 2013–2020 (USD Billion) 60
Table 6 Global Synthetic Active Pharmaceutical IngredientsMarket Size, By Type, 2013–2020 (USD Billion) 61
Table 7 Global Biotech Active Pharmaceutical Ingredient Market Size, By Region, 2013–2020 (USD Billion) 65
Table 8 North America: Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2013–2020 (USD Billion) 66
Table 9 Europe: Biotech Active Pharmaceutical Ingredients Market Size, By Region, 2013–2020 (USD Billion) 66
Table 10 Asia: Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2013–2020 (USD Billion) 67
Table 11 Global Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013–2020 (USD Billion) 68
Table 12 Global Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2013–2020 (USD Billion) 70
Table 13 Global Active Pharmaceutical Ingredients Market Size, By Type of Manufacturer, 2013–2020 (USD Billion) 74
Table 14 Active Pharmaceutical Ingredients Market Size for Captive Manufacturers, By Region, 2013–2020 (USD Billion) 75
Table 15 North America: Active Pharmaceutical Ingredients Market Size for Captive Manufacturers, By Country, 2013–2020 (USD Billion) 76
Table 16 Europe: Active Pharmaceutical Ingredients Market Size for Captive Manufacturers, By Country, 2013–2020 (USD Billion) 76
Table 17 Asia: Active Pharmaceutical Ingredients Market Size for Captive Manufacturers, By Country, 2013–2020 (USD Billion) 77
Table 18 Active Pharmaceutical Ingredients Market Size for Merchant Manufacturers, By Region, 2013–2020 (USD Billion) 78
Table 19 North America: Active Pharmaceutical Ingredients Market Size for Merchant Manufacturers, By Country, 2013–2020 (USD Billion) 79
Table 20 Europe: Active Pharmaceutical Ingredients Market Size for Merchant Manufacturers, By Country, 2013–2020 (USD Billion) 79
Table 21 Asia: Active Pharmaceutical Ingredients Market Size for Merchant Manufacturers, By Country, 2013–2020 (USD Billion) 80
Table 22 Global Active Pharmaceutical Ingredients Market Size for Merchant Manufacturers, By Type, 2013–2020 (USD Billion) 80
Table 23 Global Active Pharmaceutical Ingredients Market Size, By Type, 2013- 2020 (USD Billion) 84
Table 24 Patents Expiries, 2015 85
Table 25 Global Generic Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 87
Table 26 Active Pharmaceutical Ingredients Market Size, By Therapeutic Area, 2013–2020 (USD Billion) 89
Table 27 Cancer: Estimated Incidence, Mortality, and Prevalence (2012) 90
Table 28 Regional Estimates for Diabetes (2013) 91
Table 29 U.S.: Leading Respiratory Drugs, 2014 95
Table 30 Global High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 97
Table 31 North America: High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 98
Table 32 Europe: High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 98
Table 33 Asia: High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 99
Table 34 Global High-Potency Active Pharmaceutical Ingredients Market Size, By Type, 2013-2020 (USD Billion) 102
Table 35 Global Generic High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 103
Table 36 North America: Generic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 104
Table 37 Europe: Generic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 104
Table 38 Asia: Generic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 105
Table 39 Global High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Manufacturer, 2013-2020 (USD Billion) 106
Table 40 Global Captive High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 107
Table 41 North America: Captive High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 107
Table 42 Europe: Captive High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 108
Table 43 Asia: Captive High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 108
Table 44 Global Merchant High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 109
Table 45 North America: Merchant High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 109
Table 46 Europe: Merchant High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 110
Table 47 Asia: Merchant High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 110
Table 48 Global Merchant High-Potency Active Pharmaceutical Ingredients Market Size, By Type, 2013-2020 (USD Billion) 111
Table 49 Global High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 111
Table 50 Global Synthetic High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 112
Table 51 North America: Synthetic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 112
Table 52 Europe: Synthetic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 113
Table 53 Asia: Synthetic High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 113
Table 54 Global Synthetic High-Potency Active Pharmaceutical Ingredients Market Size, By Type, 2013-2020 (USD Billion) 114
Table 55 Global Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 114
Table 56 North America: Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 115
Table 57 Europe: Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 115
Table 58 Asia: Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Country, 2013-2020 (USD Billion) 116
Table 59 Global Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Type, 2013-2020 (USD Billion) 116
Table 60 Active Pharmaceutical Ingredients Market Size, By Region, 2013-2020 (USD Billion) 118
Table 61 North America: Market Size, By Country, 2013-2020 (USD Billion) 119
Table 62 Europe: Market Size, By Country, 2013-2020 (USD Billion) 119
Table 63 Asia: Market Size, By Country, 2013- 2020 (USD Billion) 120
Table 64 North America: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 125
Table 65 U.S.: Market Size, By Type, 2013-2020 (USD Billion) 126
Table 66 U.S.: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 126
Table 67 U.S.: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 127
Table 68 Canada: Market Size, By Type, 2013- 2020 (USD Billion) 128
Table 69 Canada: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 128
Table 70 Canada: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 129
Table 71 Europe: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 132
Table 72 U.K.: Market Size, By Type, 2013-2020 (USD Billion) 133
Table 73 U.K.: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2013-2020 (USD Billion) 133
Table 74 U.K.: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 134
Table 75 France: Market Size, By Type, 2013- 2020 (USD Billion) 135
Table 76 France: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 135
Table 77 France: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 136
Table 78 Germany: Market Size, By Type, 2013- 2020 (USD Billion) 137
Table 79 Germany: Biotech Active Pharmaceutical Ingredient Market Size, By Product, 2013-2020 (USD Billion) 137
Table 80 Germany: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 138
Table 81 Spain: Market Size, By Type, 2013- 2020 (USD Billion) 139
Table 82 Spain: Biotech Active Pharmaceutical Ingredient Market Size, By Product, 2013-2020 (USD Billion) 139
Table 83 Spain: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 140
Table 84 Italy: Market Size, By Type, 2013- 2020 (USD Billion) 140
Table 85 Italy: Biotech Active Pharmaceutical Ingredient Market Size, By Product, 2013-2020 (USD Billion) 141
Table 86 Italy: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 141
Table 87 RoE: Market Size, By Type, 2013-2020 (USD Billion) 142
Table 88 RoE: Biotech Active Pharmaceutical Ingredient Market Size, By Product, 2013-2020 (USD Billion) 143
Table 89 RoE: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 143
Table 90 Asia: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 144
Table 91 India: Market Size, By Type, 2013- 2020 (USD Billion) 145
Table 92 India: Biotech Active Pharmaceutical Ingredient Market Size, By Product, 2013-2020 (USD Billion) 145
Table 93 India: High-Potency Active Pharmaceutical Ingredient Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 146
Table 94 Japan: Market Size, By Type, 2013- 2020 (USD Billion) 147
Table 95 Japan: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 147
Table 96 Japan: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 148
Table 97 South Korea: Market Size, By Type, 2013-2020 (USD Billion) 149
Table 98 South Korea: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 149
Table 99 South Korea: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 150
Table 100 China: Market Size, By Type, 2013- 2020 (USD Billion) 151
Table 101 China: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 151
Table 102 China: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 152
Table 103 RoA: Market Size, By Type, 2013-2020 (USD Billion) 152
Table 104 RoA: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 153
Table 105 RoA: High-Potency Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2013-2020 (USD Billion) 153
Table 106 RoW: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 154
Table 107 RoW: Biotech High-Potency Active Pharmaceutical Ingredients Market Size, By Product, 2013-2020 (USD Billion) 155
Table 108 New Product Launches 158
Table 109 Mergers and Acquisitions 159
Table 110 Partnerships, Agreements, Collaborations, and Joint Ventures 160
Table 111 Expansions 161
Table 112 Sun Pharmaceuticals Industries Ltd. 197
Table 113 Teva Pharmaceutical Industries Limited 197
Table 114 Dr. Reddy’s Laboratories 199
Table 115 Aurobindo Pharma 200
Table 116 Novartis 200
Table 117 Boehringer Ingelheim 201
Table 118 Albemarle Corporation 202
Table 119 Sigma-Aldrich 202
Table 120 Mylan Inc. 203
Table 121 Allergan PLC. 203

List of Figures (56 Figures)

Figure 1 Global Active Pharmaceutical Ingredient Market 19
Figure 2 Research Design 21
Figure 3 Bottom-Up Approach 26
Figure 4 Top-Down Approach 27
Figure 5 Data Triangulation Methodology 28
Figure 6 API Market, By Type (2015 vs 2020): the Innovative API Segment to Dominate Market in the Forecast Period 30
Figure 7 Captive Manufacturers Segment to Hold Largest Market Share in 2015 31
Figure 8 Synthetic APIS Segment to Command Largest Market Share in 2015 32
Figure 9 Oncology Segment to Form Largest Market Share in 2015 33
Figure 10 API Market, By Region: North America to Command Largest Share in 2015 34
Figure 11 Hpapi Market, By Type (2015 vs 2020): the Innovative Hpapi Segment to Dominate Market in the Forecast Period 35
Figure 12 Hpapi Market, By Type of Manufacturer (2015 vs 2020): the Captive APIS Segment to Dominate Market in the Forecast Period 36
Figure 13 Hpapi Market, By Mode of Synthesis (2015 vs 2020): Synthetic APIS to Dominate Market in the Forecast Period 37
Figure 14 Hpapi Market, By Region: North America to Command Largest Share in 2015 38
Figure 15 Generic Active Pharmaceutical Ingredient Offer High Growth Opportunities 39
Figure 16 The Oncology Segment to Account for the Largest Share of the Market (2015–2020) 40
Figure 17 Synthetic Active Pharmaceutical Ingredient to Command the Largest Share in 2015 41
Figure 18 Merchant Manufacturers Segment to Grow at the Highest Rate From 2015 to 2020 42
Figure 19 the Asian Region to Witness Highest Growth During the Forecast Period 43
Figure 20 Generic High-Potency Active Pharmaceutical Ingredient Offer High Growth Opportunities 44
Figure 21 Synthetic High-Potency Active Pharmaceutical Ingredient to Command the Largest Share in 2015 45
Figure 22 The Merchant Manufacturers Segment to Grow at the Highest Rate From 2015 to 2020 46
Figure 23 Asia to Witness Highest Growth Rate During the Forecast Period 47
Figure 24 Active Pharmaceutical Ingredient Market Segmentation, By Type 49
Figure 25 Market Segmentation, By Synthesis Method 50
Figure 26 Market Segmentation, By Type of Manufacturer 50
Figure 27 Market Segmentation, By Therapeutic Area 51
Figure 28 Market Segmentation, By Region 52
Figure 29 Market: Drivers, Restraints, Opportunities, and Challenges 53
Figure 30 Synthetic Chemical Active Pharmaceutical Ingredient to Dominate the Global Active Pharmaceutical Ingredient Market in the Forecast Period (2015–2020) 57
Figure 31 North America to Command the Largest Share of the Global Active Pharmaceutical Ingredient Marke in the Forecast Period (2015–2020) 58
Figure 32 Generic Synthetic Active Pharmaceutical Ingredient to Witness Highest Growth in the Forecast Period (2015–2020) 61
Figure 33 Recombinant Proteins to Dominate the Biotech Active Pharmaceutical Ingredient Market in the Forecast Period (2015–2020) 64
Figure 34 North America to Account for the Largest Share of the Biotech Active Pharmaceutical Ingredient Market in the Forecast Period (2015– 2020) 65
Figure 35 The Merchant API Manufacturers Segment to Offer Significant Growth Opportunities in the Forecast Period 73
Figure 36 Captive API Manufacturers Market, By Region: Asia to Grow at the Highest CAGR During the Forecast Period 75
Figure 37 Merchant API Manufacturers Market, By Region: Asia to Grow at the Highest CAGR During the Forecast Period 78
Figure 38 Generic APIS to Witness Higher Growth Rate 83
Figure 39 Generic Active Pharmaceuticals Market, By Region: Asia to Grow at the Highest CAGR During the Forecast Period (2015–2020) 86
Figure 40 Oncology to Dominate the Active Pharmaceutical Ingredient Market in the Forecast Period 88
Figure 41 North American Active Pharmaceutical Ingredient Market Overview 123
Figure 42 European Active Pharmaceutical Ingredient Market Overview 130
Figure 43 Key Players Majorly Adopted Inorganic Growth Strategies Between 2012 and 2015 156
Figure 44 Market Evolution Framework –New Product Launches Fueled Market Growth Between 2012 and 2015 157
Figure 45 Battle for Market Share: New Product Launches Was the Key Strategy Adopted By Market Players Between 2012 and 2015 158
Figure 46 Geographic Revenue Mix for the Top 5 Players in the Active Pharmaceutical Ingredient Market 162
Figure 47 Teva Pharmaceutical Industries Ltd.: Company Snapshot 163
Figure 48 Dr. Reddy’s Laboratories Ltd.: Company Snapshot 166
Figure 49 Sun Pharmaceutical Industries Ltd.: Company Snapshot 169
Figure 50 Aurobindo Pharma Ltd.: Company Snapshot 172
Figure 51 Novartis International AG: Company Snapshot 175
Figure 52 Albemarle Corporation: Company Snapshot 178
Figure 53 Sigma-Aldrich Corporation: Company Snapshot 181
Figure 54 Mylan Inc.: Company Snapshot 184
Figure 55 Allergan PLC.: Company Snapshot 187
Figure 56 Boehringer Ingelheim: Company Snapshot 189

An active pharmaceutical ingredient (API) in a drug formulation is a biologically active compound which is responsible for eliciting a therapeutic activity.

Major factors driving the market growth are increasing global incidence of lifestyle and age-related diseases as well as cancer, technological advances in API manufacturing, increased awareness among people for better personal healthcare, government initiatives to increase availability and accessibility for better healthcare, and development of biologics and high potency API. On the other hand, stringent regulatory guidelines and global economic recession are some of the factors that may hinder the growth this market.

In this report, the API market is segmented on the basis of type, type of manufacturer, mode of synthesis, type of drug, therapeutic area and region. The report also provides an in-depth coverage on high-potency API (HPAPIs).

The active pharmaceutical ingredient market by type is categorized into innovative API and generic API. The innovative APIs segment accounted for highest share of the total API market in 2015. Patent protection of innovative APIs and higher prices compared to their generic equivalent are major factors driving the market growth for this segment.

The active pharmaceutical ingredient market, by type of manufacturer, is segmented into captive and merchant manufacturers. The captive manufacturers segment accounted for major share of the total API market. The API market is expected to be dominated by captive manufacturers in 2015; however, it is slowly losing its share to contract manufacturers, owing to the complexity and high expenses associated with in-house manufacturing of API as well as the increased competition from emerging contract manufacturers.

The merchant manufacturing segment is segmented into innovative merchant API and generic merchant API. The innovative merchant APIs market is estimated to account for the major share of larger share in 2015; however, the growth of this market is expected to slow down due to imminent patent cliff, increasing cost of innovative drugs, and significant growth opportunities for generic merchant APIs market in emerging markets of India, China, and Latin America that offer low-cost manufacturing.

The market for generic merchant API is expected to witness higher growth attributed to increasing healthcare costs, government emphasis on generics for reducing healthcare costs, and decreasing pipelines of global pharmaceutical products.

The active pharmaceutical ingredient market, by method of synthesis, is segmented into synthetic APIs and biotech APIs. The synthetic APIs market is estimated to account for the higher share; however, this share is expected to decline owing to rapid advances in the biopharmaceuticals market. The synthetic APIs market is subsegmented into innovative synthetic APIs and generic synthetic API.

Biotech API are estimated segment accounts for smaller share of the market as the use of biotechnology in pharmaceutical industry is a relatively new concept, and is still in the infancy state. However, it is expected to show high growth owing to the boom in biotechnology industry worldwide and advances in manufacturing and processing techniques of biopharmaceuticals coupled with increasing demand for the treatment of cancer and diabetes.

On the basis of therapeutic area, the APIs, market is segmented into oncology, diabetes, cardiovascular disorders, pulmonology disorders, CNS and neurological disorders, pain management, orthopedics, ophthalmology, endocrinology, gastroenterology, nephrology, and others.

The oncology segment is estimated to account for highest share of the total APIs market in 2015. Increasing prevalence of cancer worldwide and evolution of innovative treatment options in this field are driving the market growth in this segment.

On the basis of region, the active pharmaceutical ingredient market is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2015. The market in Asia is poised to witness the highest growth, attributed to increased production of generics, low cost of labor and skilled manpower, increase in disposable incomes, rising prevalence of lifestyle and age-related diseases, and increasing government emphasis on healthcare reforms in the region.

High-Potency Active Pharmaceutical Ingredient (HPAPIS) Market

The market for HPAPIs is expected to witness significant growth in the coming years. Major factors responsible for the growth of this market are advances in clinical pharmacology and oncology research, and increasing demand for oncology and hormonal therapeutics, and increasing usage of prostaglandins in ophthalmology and gynecology. On the other hand, factors such as increasing competition in the market and limited number of FDA-approved manufacturing sites are some of the factors that may restrain the growth of this market.

The HPAPIs market is divided on the basis of type, type of manufacturer, and mode of synthesis.

The HPAPIs market on the basis of type is categorized into innovative HPAPIs and generic HPAPIs. The innovative HPAPIs segment is expected to account for the higher share of the total HPAPIs market in 2015. The high share of this market is attributed to factors such as high growth in the global oncology market and increasing demand for antibody drug conjugates (ADC). Oncology is a major focus area for HPAPI applications; this drives the necessity for identification of new and innovative HPAPIs for treatment of cancer.
The generic HPAPIs segment is estimated to witness high growth in the forecast period. The high growth of this market is attributed to factors such as the impending patent cliff, increase in global spending on generics, and government initiatives encouraging the use of generics as compared to expensive innovative drugs to reduce the healthcare expenses.

On the basis of type of manufacturer, the HPAPIs market is segmented into captive HPAPIs and merchant HPAPIs. The captive HPAPIs segment is estimated to account for the larger share of the HPAPIs market. Leading pharma companies are emphasizing on developing innovative HPAPIs into a significant brand by making strategic investments for the in-house production of HPAPIs.

The merchant HPAPIs segment is expected to witness high growth in the forecast period. Growing trend of outsourcing the manufacturing of HPAPIs to CMOs and requirement of high containment and safety specifications in the development and manufacturing of toxic HPAPIs.

On the basis of mode of synthesis, the HPAPIs market is segmented into synthetic HPAPIs and biotech HPAPIs. The synthetic HPAPIs segment is estimated to hold the largest share of the market. Advantages of synthetic APIs such as ease of production, simplicity of administration, and superior pharmacodynamic properties owing to their small molecular size and high solubility and permeability are driving the market for this segment.

The market for biotech-based HPAPIs is expected to witness high growth owing to the advances in R&D of high-potency biopharmaceuticals for their applications in varied therapeutic areas and increase in their demand.

On the basis of region, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2015. The market in Asia is poised to witness the highest growth, attributed to increasing incidence and prevalence of Cancer and rising number of contract manufacturing organizations for HPAPI merchant manufacture in this region.

Available Customizations Title

Client Consult Problem Statement :

MnM’s client who is a decentralized public entity of mixed participation (nonprofit, scientific and technical), which aims to develop and implement activities of Research, Technology and Innovation technology transfer processes in the agricultural sector and was interested in project involving “Assessment of Sapogenins paste market”. The key objective for the study involved:

  1. The market potential of Sapogenins paste (varying concentrations of hecogenin & tigogenin up to 95%) on both short & long term basis in China, Europe, USA and Mexico based on various ingredients it can substitute in Pharma, Food & other industries and thereby develop a robust strategy to penetrate into the market
  2. Market potential break up by application industry and by regions, intellectual property rights & patent analysis, value chain analysis and Porter’s Five Forces analysis
  3. Prospective customer analysis by application industry and region; annual consumption volume of existing alternatives, current issues in using the current alternatives, unmet need with respect to substitute based on parameters like price, performance, etc.

Solution Provided:
  1. Methodology Adopted by MnM : MnM carried out a detailed search of the public domain an....
  1. Methodology Adopted by MnM : MnM carried out a detailed search of the public domain and its own proprietary & non-proprietary database on sapogenins paste market to orient the project, develop the industry structure including, manufacturers/suppliers, distributors, customers, associations, regulatory authorities and allied stakeholders. Also, in-depth primary interviews with various knowledge sources were conducted to develop key information required for completing the project. Major knowledge sources were manufacturers/ suppliers of existing alternatives which sapogenins paste can substitute, other participants in the supply chain of existing alternatives, potential customers of sapogenins paste for different applications, institutions (associations, regulatory authorities, etc.), independent consultants and industry experts. These interviews were used to draw out information such as substitution potential, possible concentration of sapogenins paste, major customers, end user industry demand, customer’s activity, future growth, etc. Similarly among regulatory authorities, associations and others bodies. MnM obtained detailed information on usage trends of existing alternatives, substitution potential of sapogenins paste, regulatory approvals required, cost implications, etc. Prospective customers of sapogenins paste in application industries synthesizing derivatives, hormones, steroids, food additives, industrial applications were interviewed to understand their usage trends, adaption level, current & forecast demand, etc. MNM interviewed at least three functions in each key customers to ensure that information is complete and accurate.
  2. Actual Solution Provided: - Through the detailed outcome of the study, we provided inputs on-

    Market potential of the sapogenins paste by application industry and region. Current unmet needs with the existing alternatives were identified to estimate the market potential. Value chain analysis, cost implications and regulatory approvals analysis was provided to the client for sapogenins paste market. Prospective customer of sapogenins paste by application industry and regions were also identified with their usage trends, adaption level, and current & forecast potential demand for sapogenins paste.

Value Delivered:

MnM’s client was able to understand the market potential of Sapogenins paste on both short & long term basis in China, Europe, USA and Mexico based on various ingredients it can substitute in Pharma, Food & other industries and thereby would be able to develop a strategy to penetrate into the market. Also, the market potential was provided by application industry and region help the client to focus on the high growth applications and markets for sapogenins paste. The prospective customer analysis of sapogenins paste by application industry and regions will help the client to target them in future as their potential customers.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo